Myxofibrosarcoma, from the CureRays guide library.

Myxofibrosarcoma is a soft-tissue sarcoma of older adults that usually appears as a slow-growing mass in or just under the skin of an arm or leg; it is notorious for spreading microscopic 'tails' far beyond the visible tumor, which is exactly why radiation is paired with surgery to lower the high chance of local recurrence.

What it is.

Myxofibrosarcoma is one of the most common soft-tissue sarcomas in older adults. A sarcoma is a cancer that arises in the body's connective tissues rather than in an organ lining; myxofibrosarcoma arises in fibrous tissue and is named for its 'myxoid' (gel-like) appearance under the microscope. It most often appears in or just beneath the skin of an arm or leg as a slowly enlarging, usually painless mass, and because it can feel soft and grow gradually it is sometimes mistaken for a harmless lump. What makes myxofibrosarcoma distinctive — and challenging — is its growth pattern: it sends long, microscopic, finger-like 'tails' of tumor cells creeping through the surrounding tissue far beyond the edge of the mass that can be seen or felt. These infiltrative tails are the single most important feature of the disease, because they are easy to leave behind during surgery, and they are the reason myxofibrosarcoma has one of the highest tendencies of any sarcoma to come back where it started if it is not treated thoroughly. The tumor ranges from low-grade (slow-growing and unlikely to spread) to high-grade (more aggressive and able to spread, most often to the lungs). The cornerstone of treatment is surgery to remove the tumor with a generous margin of healthy tissue, guided by MRI to map the extent of those tails. Radiation is very commonly combined with surgery — before or after — precisely to treat the wide zone of microscopic disease that the scalpel cannot fully reach, which substantially lowers the chance of local recurrence. Chemotherapy is reserved for selected high-grade tumors at higher risk of spreading and for disease that has already spread.

How radiation treats it.

Radiation therapy treats myxofibrosarcoma by delivering focused beams of energy that damage the DNA inside tumor cells so they can no longer grow and divide. For this particular sarcoma, radiation is an especially important partner to surgery, and the reason is the tumor's defining trait: its long, microscopic, finger-like tails. Myxofibrosarcoma does not grow as a tidy ball; it sends infiltrative extensions of tumor cells creeping through the surrounding tissue far beyond the edge of the mass that can be seen or felt. Those tails are easy to leave behind during surgery, which is why this is one of the sarcomas most prone to coming back where it started. Radiation addresses exactly this problem by treating a wide zone around the tumor — designed, with the help of MRI mapping, to cover the territory the tails reach — sterilizing that microscopic disease so the cancer is far less likely to recur locally and so the limb can be preserved. Radiation can be given before or after surgery. Beforehand it uses a smaller treatment area and a lower dose, can make a limb-preserving operation with adequate margins more achievable, and is associated with better long-term limb function, though it requires extra attention to wound healing. Afterward it treats a generous tumor bed at a higher dose over a larger area when preoperative radiation wasn't given. Because the target is often elongated to follow the tails, modern techniques such as intensity-modulated radiation are used to shape the dose tightly around that irregular volume while sparing the surrounding muscle, bone, and joints to preserve function. Radiation also has a role beyond the original site: when a high-grade myxofibrosarcoma spreads to a limited number of spots in the lungs, focused high-dose radiation (stereotactic body radiation) can ablate those deposits and provide durable control without surgery. In short, radiation's strength here is treating the broad zone of microscopic disease that this uniquely infiltrative tumor leaves behind — disease that surgery alone struggles to fully remove.

The ways we can treat it.

Preoperative (neoadjuvant) radiation. Radiation given before surgery treats the infiltrative tails using a smaller field and lower dose, can make a limb-preserving operation with adequate margins more achievable, and is associated with better long-term limb function, at the cost of more wound-healing care.

Postoperative (adjuvant) radiation. Radiation to a generous tumor bed after surgery, used when preoperative radiation wasn't given, sterilizes the microscopic disease left behind along the tails and lowers the high chance of local recurrence, at a higher dose over a larger area.

Intensity-modulated radiation (IMRT). Shaping the beams tightly around the (often elongated) target spares surrounding muscle, bone, and joints while still covering the infiltrative tails, helping preserve limb function.

Stereotactic body radiation (SBRT) for metastases. Focused, high-dose radiation can ablate a limited number of lung metastases from high-grade tumors, offering durable control without surgery.

Questions we hear often.

Why does myxofibrosarcoma come back so often, and how is that prevented? Myxofibrosarcoma's defining feature is that it sends long, microscopic, finger-like tails of tumor cells creeping through the surrounding tissue far beyond the visible mass. These tails are easy to leave behind during surgery, which is why the tumor has one of the highest local recurrence rates of any sarcoma. Two things lower that risk: a wide surgical removal — guided by MRI that maps how far the tails reach — and radiation, given before or after surgery, that treats the broad zone of microscopic disease the scalpel cannot fully capture. Together they substantially reduce the chance of the cancer returning where it started, which is why both are usually recommended.

Does a low-grade myxofibrosarcoma still need radiation? Often yes. Even though low-grade myxofibrosarcoma rarely spreads to other organs, it shares the infiltrative tails that make this tumor so prone to coming back locally. Because of that, radiation is frequently added to surgery even for low-grade tumors, to treat the microscopic disease and lower the chance of recurrence. The decision is individualized — based on the tumor's size, location, depth, and the surgical margins — but the high tendency to recur means radiation is considered more readily here than for some other low-grade sarcomas. Careful long-term follow-up is also important.

Where does myxofibrosarcoma spread, and do I need chemotherapy? When a high-grade myxofibrosarcoma spreads, it travels through the bloodstream most often to the lungs, which is why a CT scan of the chest is part of staging and follow-up. Low-grade tumors rarely spread at all. Chemotherapy is not needed for most myxofibrosarcomas; it is reserved for large, high-grade tumors at higher risk of spreading and for disease that has already spread. The main treatment for the great majority of patients is wide surgery combined with radiation to control the tumor where it started.

This guide is informational only. It is not medical advice — please confirm anything here with your care team.